chr14-102452452-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000359520.12(TECPR2):c.3465C>A(p.Ser1155Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000744 in 1,613,698 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1155S) has been classified as Likely benign.
Frequency
Consequence
ENST00000359520.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TECPR2 | NM_014844.5 | c.3465C>A | p.Ser1155Arg | missense_variant | 16/20 | ENST00000359520.12 | NP_055659.2 | |
TECPR2 | NM_001172631.3 | c.3465C>A | p.Ser1155Arg | missense_variant | 16/17 | NP_001166102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECPR2 | ENST00000359520.12 | c.3465C>A | p.Ser1155Arg | missense_variant | 16/20 | 1 | NM_014844.5 | ENSP00000352510 | P1 | |
TECPR2 | ENST00000558678.1 | c.3465C>A | p.Ser1155Arg | missense_variant | 16/17 | 1 | ENSP00000453671 |
Frequencies
GnomAD3 genomes AF: 0.000749 AC: 114AN: 152276Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00158 AC: 391AN: 248182Hom.: 7 AF XY: 0.00159 AC XY: 214AN XY: 134604
GnomAD4 exome AF: 0.000744 AC: 1087AN: 1461304Hom.: 14 Cov.: 33 AF XY: 0.000763 AC XY: 555AN XY: 726948
GnomAD4 genome AF: 0.000741 AC: 113AN: 152394Hom.: 4 Cov.: 33 AF XY: 0.000792 AC XY: 59AN XY: 74522
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 49 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jun 13, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at